The UDP-glucose/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation
International Immunology · 2024
DOI: 10.1093/intimm/dxad050 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2024. Verfasst von Li Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Laboratory of Immune Regulation, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Eosinophilia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, a Grant-in-Aid for Scientific Research, Otsuka Toshimi Scholarship Foundation.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic disorder of the large intestine with inflammation and ulceration. The incidence and prevalence of UC have been rapidly increasing worldwide, but its etiology remains unknown. In patients with UC, the accumulation of eosinophils in the large intestinal mucosa is associated with increased disease activity. However, the molecular mechanism underlying the promotion of intestinal eosinophilia in patients with UC remains poorly understood. Here, we show that uridine diphosphate (UDP)-glucose mediates the eosinophil-dependent promotion of colonic inflammation via the purinergic receptor P2Y14. The expression of P2RY14 mRNA was upregulated in the large intestinal mucosa of patients with UC. The P2Y14 receptor ligand UDP-glucose was increased in the large intestinal tissue of mice administered dextran sodium sulfate (DSS). In addition, P2ry14 deficiency and P2Y14 receptor blockade mitigated DSS-induced colitis. Among the large intestinal immune cells and epithelial cells, eosinophils highly expressed P2ry14 mRNA. P2ry14−/− mice transplanted with wild-type bone marrow eosinophils developed more severe DSS-induced colitis compared with P2ry14−/− mice that received P2ry14-deficient eosinophils. UDP-glucose prolonged the lifespan of eosinophils and promoted gene transcription in the cells through P2Y14 receptor-mediated activation of ERK1/2 signaling. Thus, the UDP-glucose/P2Y14 receptor axis aggravates large intestinal inflammation by accelerating the accumulation and activation of eosinophils.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Laboratory of Immune Regulation, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
- WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
- Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
- Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan.
- Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan.
- Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
ORCID-Profile: Daisuke Okuzaki
Förderung
- Japan Agency for Medical Research and Development
- a Grant-in-Aid for Scientific Research
- Otsuka Toshimi Scholarship Foundation
Zitieren
APA
Liu, L., Ito, T., Li, B., Tani, H., Okuzaki, D., Motooka, D., Miyazaki, H., Ogino, T., Nakamura, S., Takeda, K., & Kayama, H. (2024). The UDP-glucose/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation. International Immunology. https://doi.org/10.1093/intimm/dxad050
Vancouver
Liu L, Ito T, Li B, Tani H, Okuzaki D, Motooka D, et al. The UDP-glucose/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation. International Immunology. 2024. doi:10.1093/intimm/dxad050
BibTeX
@article{Liu2024,
author = {Liu, Li and Ito, Takayoshi and Li, Bo and Tani, Haruka and Okuzaki, Daisuke and Motooka, Daisuke and Miyazaki, Hazuki and Ogino, Takayuki and Nakamura, Shota and Takeda, Kiyoshi and Kayama, Hisako},
title = {The UDP-glucose/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation},
journal = {International Immunology},
year = {2024},
doi = {10.1093/intimm/dxad050}
}
EUVIMED